{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:36:04Z","timestamp":1759667764917},"reference-count":5,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is scarcity of data on impact of rituximab on anthropometrical parameters (weight, height and body mass index i.e. BMI SD score (SDS)) among children with steroid-dependent nephrotic syndromes (SDNS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multicentre retrospective review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>102 children with SDNS (male: 63%; n=64), median age 7 (IQR: 4.3\u20139.6) years, received a total of 217 rituximab infusions (total 110 cycles). At median follow-up of 2.1 (IQR: 1.3\u20132.8) years, 58 (57%) children were off steroids and a significant fall in steroid threshold for relapse was noted (median 0.6; IQR 0.4\u20130.9 to median 0.3; IQR 0.12 - 0.5\u2009mg\/kg\/alternate day, p=0.005). Anthropometric parameters (BMI SDS: 0.92\u00b11.8\u2009to 0.25\u00b11.47, p=0.003; weight SDS: 0.20\u00b11.6\u2009to \u22120.11\u00b11.3, p=0.01;\u2009and height SDS: \u22120.93\u00b11.88\u2009to \u22120.45\u00b11.54, p=0.04) as well as obesity (38% to 20%, p=0.003) and short stature (11% to 3%,\u2009p=0.02) improved. Results remained significant even when analysis was restricted to children \u226412 years (n=88), (BMI SDS: 0.97\u00b11.98\u2009to 0.25\u00b11.5, p=0.001;\u2009weight SDS: 0.33\u00b11.6\u2009to 0.02\u00b11.2, p=0.01;\u2009and height SDS: \u22120.67\u00b11.84\u2009to \u22120.186\u00b11.42, p=0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Use of rituximab resulted in significant steroid sparing effect with an improvement in both growth and obesity parameters.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2019-318019","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T22:15:28Z","timestamp":1582323328000},"page":"283-285","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of rituximab on anthropometric indices among childhood steroid-dependent nephrotic syndromes"],"prefix":"10.1136","volume":"106","author":[{"given":"Rajiv","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwesha","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakil","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subal","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"2021092208351099000_106.3.283.1","unstructured":"Kidney Disease: Improving Global Outcomes . KDIGO clinical practice guideline for glomerulonephritis, 2012. Available: http:\/\/kdigo.org\/home\/glomerulonephritis-gn\/ [Accessed 1 Jul 2019]."},{"key":"2021092208351099000_106.3.283.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60541-9"},{"key":"2021092208351099000_106.3.283.3","doi-asserted-by":"crossref","unstructured":"Ahn YH , Kim SH , Han KH , et al . Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome. Medicine 2018;97:e13157. doi:10.1097\/MD.0000000000013157","DOI":"10.1097\/MD.0000000000013157"},{"key":"2021092208351099000_106.3.283.4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu267"},{"key":"2021092208351099000_106.3.283.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2792-9"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-318019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T15:40:25Z","timestamp":1632325225000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-318019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,19]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/archdischild-2019-318019"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-318019","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}